MedPath

study of the effect of Lactuca sativa on urinary symptoms related to insetion urethral Double-J stent following ureteroscopy

Phase 3
Conditions
lower urinary tract symptoms, ureteral stone.
Urinary calculus, unspecified
N20.9
Registration Number
IRCT20200801048265N1
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
60
Inclusion Criteria

Men over 18 years
Having ureteral stones above 5 mm
Negative urine culture before TUL and stenting
Unilateral ureteral stenting after urethroscopy and TUL operation for ureteral stones

Exclusion Criteria

Having a neurological disease
Bilateral ureteral stent placement
Recent ESWL
Double J ureteral stent placement during the last 6 months
History of anatomical and congenital abnormalities of kidney and urinary collection system in preoperative diagnostic examinations
History of benign prostatic hyperplasia leading to bladder outlet obstruction and LUTS symptoms
Kidney or bladder stones at the same time
History of urinary retention
Residual urine volume is more than 200 ml
Urinary tract infection (UTI) or recent positive untreated or recurrent positive urine culture, Sextually Transmitted Diseases (STD)
The presence of any underlying disease that, in the opinion of the specialist, may affect the results
Any allergy to lettuce
History of gastrointestinal bleeding
History of gastrointestinal ulcers

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reteral stent urinary symptoms. Timepoint: 2 weeks after intervention. Method of measurement: Ureteral Stent Symptoms Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath